Small intestinal fungal overgrowth
ICD-10 K63.822 is a billable code used to indicate a diagnosis of small intestinal fungal overgrowth.
Small intestinal fungal overgrowth (SIFO) is a condition characterized by an abnormal increase in fungal organisms, primarily Candida species, in the small intestine. Clinically, patients may present with symptoms such as bloating, abdominal pain, diarrhea, and malabsorption, which can lead to nutritional deficiencies. The small intestine, which plays a crucial role in digestion and nutrient absorption, can become compromised due to various factors, including antibiotic use, immunosuppression, and underlying gastrointestinal disorders like irritable bowel syndrome or Crohn's disease. Disease progression can lead to chronic gastrointestinal symptoms and may contribute to systemic issues if left untreated. Diagnosis often involves a combination of clinical evaluation, stool tests, and sometimes endoscopic procedures to assess fungal presence. It is important to differentiate SIFO from other gastrointestinal conditions, such as small intestinal bacterial overgrowth (SIBO), as treatment approaches may differ significantly. Accurate diagnosis is essential for effective management and to prevent complications associated with prolonged fungal overgrowth.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K63.822 specifically covers small intestinal fungal overgrowth, primarily involving Candida species. It is important to note that this code does not cover other gastrointestinal fungal infections or conditions related to bacterial overgrowth.
K63.822 should be used when there is clear evidence of fungal overgrowth in the small intestine, as confirmed by clinical symptoms and diagnostic testing. It is crucial to differentiate it from K63.821, which pertains to bacterial overgrowth.
Documentation for K63.822 should include clinical symptoms, results from diagnostic tests (such as stool cultures or endoscopic findings), and any relevant medical history that supports the diagnosis of small intestinal fungal overgrowth.
